Garofalo Health Care S.p.A
Garofalo Health Care S.p.A., together with its subsidiaries, operates healthcare clinics in Italy. It operates through Hospital and Social/Dependency Care segments. The company offers high-complexity surgery, medium- and low-complexity surgery, emergency surgery, medicine, clinical and interventional cardiology, and extended and intensive care units, as well as motor, neurological, cardiac, and n… Read more
Garofalo Health Care S.p.A (GHC) - Net Assets
Latest net assets as of September 2025: €348.77 Million EUR
Based on the latest financial reports, Garofalo Health Care S.p.A (GHC) has net assets worth €348.77 Million EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€856.60 Million) and total liabilities (€507.83 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €348.77 Million |
| % of Total Assets | 40.72% |
| Annual Growth Rate | 19.69% |
| 5-Year Change | 63.93% |
| 10-Year Change | N/A |
| Growth Volatility | 24.75 |
Garofalo Health Care S.p.A - Net Assets Trend (2016–2024)
This chart illustrates how Garofalo Health Care S.p.A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Garofalo Health Care S.p.A (2016–2024)
The table below shows the annual net assets of Garofalo Health Care S.p.A from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €333.14 Million | +10.72% |
| 2023-12-31 | €300.89 Million | +7.79% |
| 2022-12-31 | €279.15 Million | +7.07% |
| 2021-12-31 | €260.71 Million | +28.29% |
| 2020-12-31 | €203.22 Million | +5.83% |
| 2019-12-31 | €192.03 Million | +3.32% |
| 2018-12-31 | €185.85 Million | +82.43% |
| 2017-12-31 | €101.88 Million | +28.76% |
| 2016-12-31 | €79.12 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Garofalo Health Care S.p.A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 137.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €138.05 Million | 42.82% |
| Other Components | €184.35 Million | 57.18% |
| Total Equity | €322.40 Million | 100.00% |
Garofalo Health Care S.p.A Competitors by Market Cap
The table below lists competitors of Garofalo Health Care S.p.A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SIMILARWEB LTD IS-01
F:63X
|
$126.74 Million |
|
1Stdibs.Com Inc
NASDAQ:DIBS
|
$126.75 Million |
|
Genome & Company
KQ:314130
|
$126.77 Million |
|
Karyopharm Therapeutics Inc
NASDAQ:KPTI
|
$126.81 Million |
|
Guangdong Jushen Logistics Co Ltd
SHE:001202
|
$126.68 Million |
|
Zeda Ltd.
JSE:ZZD
|
$126.62 Million |
|
MITSUBISHI STEEL MFG
F:0BK
|
$126.61 Million |
|
Sidetrade
PA:ALBFR
|
$126.60 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Garofalo Health Care S.p.A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 298,886,000 to 322,397,000, a change of 23,511,000 (7.9%).
- Net income of 21,701,000 contributed positively to equity growth.
- Share repurchases of 849,000 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €21.70 Million | +6.73% |
| Share Repurchases | €849.00K | -0.26% |
| Other Changes | €2.66 Million | +0.82% |
| Total Change | €- | 7.87% |
Book Value vs Market Value Analysis
This analysis compares Garofalo Health Care S.p.A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.27x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.89x to 1.27x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €1.19 | €4.63 | x |
| 2018-12-31 | €2.18 | €4.63 | x |
| 2019-12-31 | €2.35 | €4.63 | x |
| 2020-12-31 | €2.49 | €4.63 | x |
| 2021-12-31 | €2.92 | €4.63 | x |
| 2022-12-31 | €3.14 | €4.63 | x |
| 2023-12-31 | €3.38 | €4.63 | x |
| 2024-12-31 | €3.64 | €4.63 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Garofalo Health Care S.p.A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.73%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.64%
- • Asset Turnover: 0.55x
- • Equity Multiplier: 2.64x
- Recent ROE (6.73%) is below the historical average (7.76%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 7.15% | 4.43% | 0.73x | 2.23x | €-2.18 Million |
| 2017 | 13.83% | 8.66% | 0.70x | 2.27x | €3.65 Million |
| 2018 | 7.59% | 8.80% | 0.53x | 1.62x | €-4.30 Million |
| 2019 | 6.85% | 6.70% | 0.45x | 2.25x | €-6.05 Million |
| 2020 | 5.80% | 5.70% | 0.45x | 2.26x | €-8.53 Million |
| 2021 | 7.23% | 6.78% | 0.44x | 2.41x | €-7.21 Million |
| 2022 | 7.68% | 6.81% | 0.49x | 2.31x | €-6.48 Million |
| 2023 | 6.96% | 5.68% | 0.46x | 2.66x | €-9.09 Million |
| 2024 | 6.73% | 4.64% | 0.55x | 2.64x | €-10.54 Million |
Industry Comparison
This section compares Garofalo Health Care S.p.A's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,676,903,831
- Average return on equity (ROE) among peers: 7.96%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Garofalo Health Care S.p.A (GHC) | €348.77 Million | 7.15% | 1.46x | $126.70 Million |
| Raffles Medical Group Ltd (02M1) | $1.04 Billion | 8.64% | 0.46x | $548.22 Million |
| China Resources Medical Holdings Company Limited (1PH) | $6.14 Billion | 6.37% | 0.28x | $264.86 Million |
| Apollo Medical Holdings Inc (3AM) | $510.64 Million | 13.50% | 0.70x | $820.67 Million |
| NUVERRA ENVIR SOL (3H5) | $548.43 Million | -8.67% | 2.25x | $95.85 Million |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.04 Billion | 6.61% | 0.54x | $9.60 Million |
| Medicover AB (5M0B) | $562.10 Million | 18.11% | 2.00x | $967.15 Million |
| Ambea AB (publ) (6MA) | $4.68 Billion | 7.82% | 2.82x | $937.47 Million |
| Eifelhöhen-Klinik AG (EIF) | $18.66 Million | 24.17% | 2.10x | $4.38 Million |
| GZ4 (GZ4) | $545.91 Million | -4.85% | 4.17x | $116.32 Million |